Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 9Thoracic 3Gastrointestinal 3Gynecologic 2Tumor-Agnostic 1Genitourinary 1

Conditions

Lung Neoplasms 3

Interventions

Carboplatin 1145Cisplatin 874Pemetrexed 832pembrolizumab 604Paclitaxel 597Docetaxel 535Gemcitabine 424Radiotherapy 374Erlotinib Hydrochloride 367Nivolumab 322Bevacizumab 322Etoposide 294durvalumab 254Drug Therapy 233osimertinib 217atezolizumab 207Radiosurgery 188Gefitinib 177Vinorelbine 145130-nm albumin-bound paclitaxel 123Magnetic Resonance Spectroscopy 120Ipilimumab 118Cetuximab 113anlotinib 104tislelizumab 103Topotecan 101Cyclophosphamide 101Taxes 99Irinotecan 95Albumin-Bound Paclitaxel 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Relaxation Therapy × Thoracic × Clear all
NCT05339022 2025-11-21

Supportive Care Intervention (ROAR-LCT) for Patients With Stage IIIA, IIIB, and IV Lung Cancer, ROAR-LCT Trial

Ohio State University Comprehensive Cancer Center

Phase NA Completed
100 enrolled
Thoracic

Lung Neoplasms

NCT04229381 2023-11-15

ROAR-LCT

Ohio State University Comprehensive Cancer Center

Phase NA Completed
18 enrolled 9 charts
Thoracic

Lung Neoplasms

NCT02938104 2018-03-22

Multimodal Prehabilitation to Enhance Functional Recovery After Lung Surgery

McGill University Health Centre/Research Institute of the McGill University Health Centre

Phase NA Completed
120 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡